Suven Pharmaceuticals consolidated net profit rises 10.29% in the March 2022 quarter

9 May 2022 , 02:13 PM

Net profit of Suven Pharmaceuticals rose 10.29% to Rs 91.67 crore in the quarter ended March 2022 as against Rs 83.12 crore during the previous quarter ended March 2021. Sales rose 40.40% to Rs 363.85 crore in the quarter ended March 2022 as against Rs 259.16 crore during the previous quarter ended March 2021. For the full year,net profit rose 25.24% to Rs 453.80 crore in the year ended March 2022 as against Rs 362.34 crore during the previous year ended March 2021. Sales rose 30.75% to Rs 1320.22 crore in the year ended March 2022 as against Rs 1009.72 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	363.85	259.16	40	1320.22	1009.72	31
OPM %	43.16	36.15	–	43.89	43.62	–
PBDT	171.70	113.78	51	706.69	499.31	42
PBT	161.28	105.47	53	667.59	467.67	43
NP	91.67	83.12	10	453.80	362.34	25

Powered by Capital Market – Live News